Latest Information Update: 22 Mar 2010
At a glance
- Originator Intendis
- Class Antipsoriatics; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 12 Jul 2006 This compound is still in active development